Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation

E. Santillo, M. Migale, D. Postacchini, L. Fallavollita, L. Marini, F. Balestrini

Research output: Contribution to journalArticle

Abstract

We report the case of an elderly woman with coronary heart disease and paroxysmal atrial fibrillation. It could be hypothesized that the predisposing anatomic substrate for arrhythmogenesis in this patient derived from both age-related left atrial dilation and coexistent ischaemic heart disease. Unfortunately the usual antiarrhythmic therapy was unsafe or not feasible for this subject. Ranolazine 750 mg twice daily completely suppressed atrial fibrillation recurrences.

Original languageEnglish
JournalClinica Terapeutica
Volume165
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Atrial Fibrillation
Myocardial Ischemia
Coronary Disease
Dilatation
Recurrence
Ranolazine
Therapeutics

Keywords

  • Atrial fibrillation
  • Elderly
  • Ranolazine
  • Rhythm control

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation. / Santillo, E.; Migale, M.; Postacchini, D.; Fallavollita, L.; Marini, L.; Balestrini, F.

In: Clinica Terapeutica, Vol. 165, No. 2, 2014.

Research output: Contribution to journalArticle

@article{0ea449d1019247c89942042e20e2b355,
title = "Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation",
abstract = "We report the case of an elderly woman with coronary heart disease and paroxysmal atrial fibrillation. It could be hypothesized that the predisposing anatomic substrate for arrhythmogenesis in this patient derived from both age-related left atrial dilation and coexistent ischaemic heart disease. Unfortunately the usual antiarrhythmic therapy was unsafe or not feasible for this subject. Ranolazine 750 mg twice daily completely suppressed atrial fibrillation recurrences.",
keywords = "Atrial fibrillation, Elderly, Ranolazine, Rhythm control",
author = "E. Santillo and M. Migale and D. Postacchini and L. Fallavollita and L. Marini and F. Balestrini",
year = "2014",
doi = "10.7471/CT.2014.1703",
language = "English",
volume = "165",
journal = "Clinica Terapeutica",
issn = "0009-9074",
publisher = "Societa Editrice Universo",
number = "2",

}

TY - JOUR

T1 - Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation

AU - Santillo, E.

AU - Migale, M.

AU - Postacchini, D.

AU - Fallavollita, L.

AU - Marini, L.

AU - Balestrini, F.

PY - 2014

Y1 - 2014

N2 - We report the case of an elderly woman with coronary heart disease and paroxysmal atrial fibrillation. It could be hypothesized that the predisposing anatomic substrate for arrhythmogenesis in this patient derived from both age-related left atrial dilation and coexistent ischaemic heart disease. Unfortunately the usual antiarrhythmic therapy was unsafe or not feasible for this subject. Ranolazine 750 mg twice daily completely suppressed atrial fibrillation recurrences.

AB - We report the case of an elderly woman with coronary heart disease and paroxysmal atrial fibrillation. It could be hypothesized that the predisposing anatomic substrate for arrhythmogenesis in this patient derived from both age-related left atrial dilation and coexistent ischaemic heart disease. Unfortunately the usual antiarrhythmic therapy was unsafe or not feasible for this subject. Ranolazine 750 mg twice daily completely suppressed atrial fibrillation recurrences.

KW - Atrial fibrillation

KW - Elderly

KW - Ranolazine

KW - Rhythm control

UR - http://www.scopus.com/inward/record.url?scp=84899719941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899719941&partnerID=8YFLogxK

U2 - 10.7471/CT.2014.1703

DO - 10.7471/CT.2014.1703

M3 - Article

C2 - 24770828

AN - SCOPUS:84899719941

VL - 165

JO - Clinica Terapeutica

JF - Clinica Terapeutica

SN - 0009-9074

IS - 2

ER -